SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shilpa Medicare - Quaterly Results

10 Feb 2025 Evaluate
The topline for the December 2024 quarter moved up 95.98% to Rs. 1253.87 millions as compared to Rs. 639.79 millions during the year-ago period.Net Profit witnessed a 497.55% growth almost the double from Rs. 26.98 millions to Rs. 161.22  millions  of same quarter last year.Operating Profit saw a handsome growth to 393.89 millions from 190.29 millions in the quarter ended December 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 1253.87 639.79 95.98 3511.88 2223.34 57.96 3097.87 2477.02 25.06
Other Income 168.26 223.26 -24.63 697.49 658.69 5.89 891.16 686.44 29.82
PBIDT 393.89 190.29 106.99 1591.20 852.02 86.76 1154.08 246.42 368.34
Interest 13.76 26.08 -47.24 45.15 145.46 -68.96 172.57 208.25 -17.13
PBDT 375.27 163.03 130.18 1531.88 639.89 139.40 877.00 -117.30 -847.66
Depreciation 121.95 123.94 -1.61 365.17 373.24 -2.16 496.11 465.48 6.58
PBT 253.32 39.09 548.04 1166.71 266.65 337.54 380.89 -582.78 -165.36
TAX 92.10 12.11 660.53 417.10 94.64 340.72 111.52 -87.93 -226.83
Deferred Tax -43.54 -0.83 5145.78 -37.04 3.62 -1123.20 -1.35 -4.27 -68.38
PAT 161.22 26.98 497.55 749.61 172.01 335.79 269.37 -494.85 -154.43
Equity 97.79 86.80 12.66 97.79 86.80 12.66 86.80 86.80 0.00
PBIDTM(%) 31.41 29.74 5.62 45.31 38.32 18.23 37.25 9.95 274.48

Shilpa Medicare Share Price

411.55 0.30 (0.07%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×